Cases & Deals

Baxalta merges with Shire in $32 billion biotechnology deal

Client(s) Baxalta Incorporated

Jones Day represented Baxalta Incorporated, a biopharmaceutical manufacturer headquartered in Northern Illinois, as global antitrust and competition law counsel in its $32 billion merger with Ireland based Shire plc to create a leading biotechnology company focused on treatments for rare diseases.